The Anti-Influenza Virus Agent 4-GU-DANA (Zanamivir) Inhibits Cell Fusion Mediated by Human Parainfluenza Virus and Influenza Virus HA

Eitemau Tebyg

• Mutations in Human Parainfluenza Virus Type 3 Hemagglutinin-Neuraminidase Causing Increased Receptor Binding Activity and Resistance to the Transition State Sialic Acid Analog 4-GU-DANA (Zanamivir)
  gan: Murrell, Matthew, et al.
  Cyhoeddwyd: (2003)
• A Single Amino Acid Alteration in the Human Parainfluenza Virus Type 3 Hemagglutinin-Neuraminidase Glycoprotein Confers Resistance to the Inhibitory Effects of Zanamivir on Receptor Binding and Neuraminidase Activity
  gan: Murrell, Matthew T., et al.
  Cyhoeddwyd: (2001)
• Live Bivalent Vaccine for Parainfluenza and Influenza Virus Infections
  gan: Maeda, Yasuko, et al.
  Cyhoeddwyd: (2005)
• Resistance to Mutant Group 2 Influenza Virus Neuraminidases of an Oseltamivir-Zanamivir Hybrid Inhibitor
  gan: Wu, Yan, et al.
  Cyhoeddwyd: (2016)
• Chemoprophylaxis of Influenza A Virus Infections, with Single Doses of Zanamivir, Demonstrates that Zanamivir Is Cleared Slowly from the Respiratory Tract
  gan: Fenton, Robert J., et al.
  Cyhoeddwyd: (1999)